USANA Health Sciences, Inc. (NYSE:USNA) Holdings Raised by XTX Topco Ltd

XTX Topco Ltd grew its position in USANA Health Sciences, Inc. (NYSE:USNAFree Report) by 62.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,449 shares of the company’s stock after acquiring an additional 4,010 shares during the quarter. XTX Topco Ltd owned approximately 0.06% of USANA Health Sciences worth $282,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in USNA. Royce & Associates LP grew its stake in shares of USANA Health Sciences by 15.2% in the first quarter. Royce & Associates LP now owns 44,835 shares of the company’s stock worth $1,209,000 after purchasing an additional 5,921 shares in the last quarter. KLP Kapitalforvaltning AS grew its stake in shares of USANA Health Sciences by 373.9% in the first quarter. KLP Kapitalforvaltning AS now owns 10,900 shares of the company’s stock worth $294,000 after purchasing an additional 8,600 shares in the last quarter. Denali Advisors LLC bought a new position in shares of USANA Health Sciences in the first quarter worth $443,000. Pzena Investment Management LLC grew its stake in shares of USANA Health Sciences by 0.7% in the first quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company’s stock worth $29,537,000 after purchasing an additional 8,110 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in shares of USANA Health Sciences by 2.7% in the first quarter. Principal Financial Group Inc. now owns 55,076 shares of the company’s stock worth $1,485,000 after purchasing an additional 1,473 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Thursday, May 22nd.

View Our Latest Report on USANA Health Sciences

USANA Health Sciences Trading Up 1.6%

Shares of NYSE USNA opened at $29.32 on Tuesday. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $41.83. The company has a market capitalization of $535.66 million, a price-to-earnings ratio of 16.29, a PEG ratio of 0.92 and a beta of 0.61. The firm has a 50-day moving average of $30.81 and a two-hundred day moving average of $29.67.

USANA Health Sciences (NYSE:USNAGet Free Report) last announced its earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.54 by $0.20. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. The business had revenue of $235.85 million during the quarter, compared to the consensus estimate of $225.20 million. As a group, research analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, COO Walter Noot sold 6,291 shares of the company’s stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider David Mulham Mulham sold 3,515 shares of the stock in a transaction dated Wednesday, July 30th. The shares were sold at an average price of $30.26, for a total value of $106,363.90. Following the transaction, the insider directly owned 9,260 shares in the company, valued at approximately $280,207.60. This represents a 27.51% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,364 shares of company stock valued at $342,536. Company insiders own 0.63% of the company’s stock.

About USANA Health Sciences

(Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

See Also

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.